The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1036

Jock
I didn't say that things were better under Roger, if you remember I was one of the first that said it was time for Roger to go.
Now when I first suggested this a lot on here called me an idiot and said I didn't know what I was talking about.
What I now am saying is that my expectations (even with my glass half empty outlook) have failed to be delivered
Now why is that so, well MT has stated currently he sees the value of the company around $2.5b but could be worth up to $7.5b, it has also been made clear that management would accept a reasonable offer for the company or even a partnership offer.
It was also stated here that big pharmas are not silly, so why have they not at least made an offer based on the data currently known.
Why hasn't paa progressed with the registration canine trial
Why is the sp struggling to get over 40 cents
Why are we still waiting on ODD application outcome could it because MT failed to include any known data with the ODD application
Posters prior to MT joining the company was putting a much higher sp then it currently is
So maybe MT has done his best and the sp is where it should be and my expectations are way out